Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-02-10 @ 2:51 AM
Study NCT ID:
NCT06438367
Status:
COMPLETED
Last Update Posted:
2025-02-21
First Post:
2024-05-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TGRX-326 Pharmacokinetic Mass Balance
Sponsor:
Shenzhen TargetRx, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non Small Cell Lung Cancer | View |
Keywords: